Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, Kuruswamy Thurai Prasad & Ritesh Agarwal. (2020) An overview of the available treatments for chronic cavitary pulmonary aspergillosis. Expert Review of Respiratory Medicine 14:7, pages 715-727.
Read now
Read now
Sho Yamazaki, Fumihiko Nakamura, Akihide Yoshimi, Motoshi Ichikawa, Yasuhito Nannya & Mineo Kurokawa. (2014) Safety of high-dose micafungin for patients with hematological diseases. Leukemia & Lymphoma 55:11, pages 2572-2576.
Read now
Read now
Byung Woo Jhun, Kyeongman Jeon, Jung Seop Eom, Ji Hyun Lee, Gee Young Suh, O Jung Kwon & Won-Jung Koh. (2013) Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Medical Mycology 51:8, pages 811-817.
Read now
Read now
Shigeru Kohno, Koichi Izumikawa, Hiroshi Kakeya, Yoshitsugu Miyazaki, Kenji Ogawa, Ryoichi Amitani, Yoshihito Niki & Atsuyuki Kurashima. (2011) Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study. Medical Mycology 49:7, pages 688-693.
Read now
Read now
Richard F Hector & Donald E Bierer. (2011) New β-glucan inhibitors as antifungal drugs. Expert Opinion on Therapeutic Patents 21:10, pages 1597-1610.
Read now
Read now
Takayoshi Tashiro, Koichi Izumikawa, Masato Tashiro, Takahiro Takazono, Yoshitomo Morinaga, Kazuko Yamamoto, Yoshifumi Imamura, Taiga Miyazaki, Masafumi Seki, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara, Akira Yasuoka & Shigeru Kohno. (2011) Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Medical Mycology 49:6, pages 581-587.
Read now
Read now
Oliver A Cornely, Peter G Pappas, Jo-Anne H Young, Philip Maddison & Andrew J Ullmann. (2011) Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases. Expert Opinion on Drug Safety 10:2, pages 171-183.
Read now
Read now
Alison M Bormann & Vicki A Morrison. (2009) Review of the pharmacology and clinical studies of micafungin. Drug Design, Development and Therapy 3, pages 295-302.
Read now
Read now
Fumiaki Ikeda, Takeshi Saika, Yumie Sato, Makoto Suzuki, Miyuki Hasegawa, Takashi Mikawa, Intetsu Kobayashi & Akiyoshi Tsuji. (2009) Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan. Medical Mycology 47:2, pages 145-148.
Read now
Read now
Kazuo Tamura, Akio Urabe, Minoru Yoshida, Akihisa Kanamaru, Yoshihisa Kodera, Shinichiro Okamoto, Shigefumi Maesaki & Tohru Masaoka. (2009) Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders. Leukemia & Lymphoma 50:1, pages 92-100.
Read now
Read now
Hiroto Narimatsu & Masahiro Kami. (2008) Management of fungal infections following allogeneic stem cell transplantation. Expert Review of Anti-infective Therapy 6:3, pages 373-384.
Read now
Read now
Shelley S Magill, Tom M Chiller & David W Warnock. (2008) Evolving strategies in the management of aspergillosis. Expert Opinion on Pharmacotherapy 9:2, pages 193-209.
Read now
Read now
Gregory Eschenauer, Daryl D DePestel & Peggy L Carver. (2007) Comparison of echinocandin antifungals. Therapeutics and Clinical Risk Management 3:1, pages 71-97.
Read now
Read now
Rose Kim, Deborah Khachikian & Annette C Reboli. (2007) A comparative evaluation of properties and clinical efficacy of the echinocandins. Expert Opinion on Pharmacotherapy 8:10, pages 1479-1492.
Read now
Read now
Koichi Izumikawa, Yoshiko Ohtsu, Masateru Kawabata, Hisashi Takaya, Atsushi Miyamoto, Susumu Sakamoto, Kazuma Kishi, Eiyasu Tsuboi, Sakae Homma & Kunihiko Yoshimura. (2007) Clinical efficacy of micafungin for chronic pulmonary aspergillosis. Medical Mycology 45:3, pages 273-278.
Read now
Read now
Joshua Perlroth, Bryan Choi & Brad Spellberg. (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Medical Mycology 45:4, pages 321-346.
Read now
Read now
George Aperis, Nikolaos Myriounis, Elias K Spanakis & Eleftherios Mylonakis. (2006) Developments in the treatment of candidiasis: more choices and new challenges. Expert Opinion on Investigational Drugs 15:11, pages 1319-1336.
Read now
Read now
Jörg J Vehreschild & Oliver A Cornely. (2006) Micafungin Sodium, the Second of the Echinocandin Class of Antifungals: Theory and Practice. Future Microbiology 1:2, pages 161-170.
Read now
Read now
Michelle S Turner, Richard H Drew & John R Perfect. (2006) Emerging echinocandins for treatment of invasive fungal infections. Expert Opinion on Emerging Drugs 11:2, pages 231-250.
Read now
Read now
Vicki A Morrison. (2006) Echinocandin antifungals: review and update. Expert Review of Anti-infective Therapy 4:2, pages 325-342.
Read now
Read now
Aimee K Zaas & Barbara D Alexander. (2005) Echinocandins: role in antifungal therapy, 2005. Expert Opinion on Pharmacotherapy 6:10, pages 1657-1668.
Read now
Read now
Andreas H Groll, Theodouli Stergiopoulou, Emmanuel Roilides & Thomas J Walsh. (2005) Micafungin: pharmacology, experimental therapeutics and clinical applications. Expert Opinion on Investigational Drugs 14:4, pages 489-509.
Read now
Read now
Articles from other publishers (100)
Masato TASHIRO, Takahiro TAKAZONO & Koichi IZUMIKAWA. (2023) Pathogenesis, Treatment Approaches and Challenges of Drug Resistance in Chronic Pulmonary Aspergillosis慢性肺アスペルギルス症の病態，治療戦略，および薬剤耐性の諸問題. Kansenshogaku Zasshi 97:3, pages 75-89.
Crossref
Crossref
Abby P. Douglas, Olivia. C. Smibert, Ashish Bajel, Catriona L. Halliday, Orly Lavee, Brendan McMullan, Michelle K. Yong, Sebastiaan J. van Hal & Sharon C.‐A. Chen. (2021) Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Internal Medicine Journal 51:S7, pages 143-176.
Crossref
Crossref
Minoru Yoshida. (2021) Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections. International Journal of Molecular Sciences 22:17, pages 9265.
Crossref
Crossref
Kazuhito Nomura, Sonoko Sakawaki, Eiji Sakawaki, Ayumu Yamaoka, Wakiko Aisaka, Hiroyuki OkamotoYoshihiro Takeyama, Shuji Uemura & Eichi Narimatsu. (2021) Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine. Medicine 100:19, pages e25967.
Crossref
Crossref
Maria Siopi, David S. Perlin, Maiken C. Arendrup, Spyros Pournaras & Joseph Meletiadis. (2021)
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an
In Vitro
Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?
. Antimicrobial Agents and Chemotherapy 65:4.
Crossref
Crossref
Alexander J. Lepak & David R. Andes. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology
438
448
.
Felix Bongomin, Lucy Grace Asio, Ronald Olum & David W. Denning. (2020) Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta‐analysis. Mycoses 63:9, pages 921-927.
Crossref
Crossref
Felix Bongomin, Lucy Grace Asio, Joseph Baruch Baluku, Richard Kwizera & David W. Denning. (2020) Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist. Journal of Fungi 6:2, pages 75.
Crossref
Crossref
William Osborne, Michelle Fernandes, Sophie Brooks, Emily Grist, Charlie Sayer, David M. Hansell, Robert Wilson, Anand Shah & Michael R. Loebinger. (2020) Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre. The Clinical Respiratory Journal 14:6, pages 571-577.
Crossref
Crossref
Alexander V. Veselov. (2020) The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections. Clinical Microbiology and Antimicrobial Chemotherapy, pages 197-209.
Crossref
Crossref
Takeo Yasu, Takaaki Konuma, Maki Oiwa-Monna, Mai Mizusawa, Masamichi Isobe, Seiko Kato, Satoshi Takahashi & Arinobu Tojo. (2019) Efficacy and safety of micafungin in unrelated cord blood transplant recipients. Annals of Hematology 98:11, pages 2593-2600.
Crossref
Crossref
David A. Enoch, Michael E. Murphy, Christianne Micallef, Huina Yang, Nicholas M. Brown & Sani H. Aliyu. (2018) Micafungin use in a UK tertiary referral hospital. Journal of Global Antimicrobial Resistance 15, pages 82-87.
Crossref
Crossref
Haruka Sato, Fumito Okada, Shunro Matsumoto, Hiromu Mori, Junji Kashiwagi, Eiji Komatsu, Toru Maeda, Haruto Nishida, Tsutomu Daa, Satoshi Ohtani, Kenji Umeki, Masaru Ando & Junichi Kadota. (2018) RETRACTED ARTICLE: The scab-like sign: A CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?. European Radiology 28:10, pages 4053-4061.
Crossref
Crossref
A.J. Ullmann, J.M. Aguado, S. Arikan-Akdagli, D.W. Denning, A.H. Groll, K. Lagrou, C. Lass-Flörl, R.E. Lewis, P. Munoz, P.E. Verweij, A. Warris, F. Ader, M. Akova, M.C. Arendrup, R.A. Barnes, C. Beigelman-Aubry, S. Blot, E. Bouza, R.J.M. Brüggemann, D. Buchheidt, J. Cadranel, E. Castagnola, A. Chakrabarti, M. Cuenca-Estrella, G. Dimopoulos, J. Fortun, J.-P. Gangneux, J. Garbino, W.J. Heinz, R. Herbrecht, C.P. Heussel, C.C. Kibbler, N. Klimko, B.J. Kullberg, C. Lange, T. Lehrnbecher, J. Löffler, O. Lortholary, J. Maertens, O. Marchetti, J.F. Meis, L. Pagano, P. Ribaud, M. Richardson, E. Roilides, M. Ruhnke, M. Sanguinetti, D.C. Sheppard, J. Sinkó, A. Skiada, M.J.G.T. Vehreschild, C. Viscoli & O.A. Cornely. (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection 24, pages e1-e38.
Crossref
Crossref
Felix Bongomin, Chris Harris, Gemma Hayes, Chris Kosmidis & David W. Denning. (2018) Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLOS ONE 13:4, pages e0193732.
Crossref
Crossref
Subramanian Swaminathan, Shweta Kamat & Nalini Adele Pinto. (2018) Echinocandins: Their Role in the Management of Candida Biofilms. Indian Journal of Medical Microbiology 36:1, pages 87-92.
Crossref
Crossref
Amarish Kumar Sharma & Anjana Rana Sharma. 2018. Fungi and their Role in Sustainable Development: Current Perspectives. Fungi and their Role in Sustainable Development: Current Perspectives
483
503
.
Anthony J. Perissinotti & Bernard L. Marini. (2017) Real-Life Challenges to the Use of Antifungal Agents in Hematology Patients. Current Fungal Infection Reports 11:4, pages 229-241.
Crossref
Crossref
Akash Patil & Soumyajit Majumdar. (2017) Echinocandins in antifungal pharmacotherapy. Journal of Pharmacy and Pharmacology 69:12, pages 1635-1660.
Crossref
Crossref
D. W. Denning,J. Cadranel, C. Beigelman-Aubry, F. Ader, A. Chakrabarti, S. Blot, A. J. Ullmann & G. Dimopoulos. (2017) Diagnosis and treatment of chronic pulmonary aspergillosis: clinical guidelines of European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society. PULMONOLOGIYA 26:6, pages 657-679.
Crossref
Crossref
David W. Denning, Jacques Cadranel, Catherine Beigelman-Aubry, Florence Ader, Arunaloke Chakrabarti, Stijn Blot, Andrew J. Ullmann, George Dimopoulos & Christoph Lange. (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. European Respiratory Journal 47:1, pages 45-68.
Crossref
Crossref
Helmut J.F. Salzer, Nasstasja Wassilew, Niklas Köhler, Ioana D. Olaru, Gunar Günther, Christian Herzmann, Barbara Kalsdorf, Patricia Sanchez-Carballo, Elena Terhalle, Thierry Rolling, Christoph Lange & Jan Heyckendorf. (2016) Personalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis. Respiration 92:4, pages 199-214.
Crossref
Crossref
Piyush Baindara & Suresh Korpole. 2016. Recent Trends in Antifungal Agents and Antifungal Therapy. Recent Trends in Antifungal Agents and Antifungal Therapy
97
121
.
Chie Kobayashi, Tomoko Hanadate, Toshiro Niwa, Takashi Yoshiyasu, Masahiro So & Keita Matsui. (2015) Safety and Effectiveness of Micafungin in Japanese Pediatric Patients. Journal of Pediatric Hematology/Oncology 37:5, pages e285-e291.
Crossref
Crossref
Paul E. Verweij, Michelle Ananda-Rajah, David Andes, Maiken C. Arendrup, Roger J. Brüggemann, Anuradha Chowdhary, Oliver A. Cornely, David W. Denning, Andreas H. Groll, Koichi Izumikawa, Bart Jan Kullberg, Katrien Lagrou, Johan Maertens, Jacques F. Meis, Pippa Newton, Iain Page, Seyedmojtaba Seyedmousavi, Donald C. Sheppard, Claudio Viscoli, Adilia Warris & J. Peter Donnelly. (2015) International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resistance Updates 21-22, pages 30-40.
Crossref
Crossref
Tsutomu Maeno, Masakazu Sasaki, Yasushi Shibue, Kazuyuki Mimura & Hideaki Oka. (2015) Calcium oxalate in the sputum may aid in the diagnosis of pulmonary aspergillosis: A report of two cases. Medical Mycology Case Reports 8, pages 32-36.
Crossref
Crossref
Chie Kobayashi, Tomoko Hanadate, Toshiro Niwa, Yasuno Hirano, Takashi Yoshiyasu, Masahiro So & Keita Matsui. (2015) Safety and efficacy of micafungin for prophylaxis against invasive fungal infections in Japanese patients undergoing hematopoietic stem cell transplantation: Results of a post-marketing surveillance study. Journal of Infection and Chemotherapy 21:6, pages 438-443.
Crossref
Crossref
John H. Rex & David A. Stevens. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
479
494.e4
.
Paolo Manzoni, Chunzhang Wu, Lorraine Tweddle & Emmanuel Roilides. (2014) Micafungin in Premature and Non-premature Infants. Pediatric Infectious Disease Journal 33:11, pages e291-e298.
Crossref
Crossref
F. Javier Pastor & Josep Guarro. (2014) Treatment of Aspergillus terreus infections: A clinical problem not yet resolved. International Journal of Antimicrobial Agents 44:4, pages 281-289.
Crossref
Crossref
D.A. Enoch, S.F. Idris, S.H. Aliyu, C. Micallef, O. Sule & J.A. Karas. (2014) Micafungin for the treatment of invasive aspergillosis. Journal of Infection 68:6, pages 507-526.
Crossref
Crossref
Takafumi Sugawara, Noritaka Murakami, Nobue Uetake, Shunji Matsumoto, Shinichi Miyamori, Ryouichi Okamoto & Kouichi Hiraki. (2014) Relationship between the Effectiveness and Dose of Micafungin in the Treatment of Candidemiaカンジダ血流感染症に対するミカファンギンの投与量と有効性に関する検討. YAKUGAKU ZASSHI 134:3, pages 433-438.
Crossref
Crossref
Takayuki Takeda, Hideki Itano, Ryouhei Kakehashi, Shinichi Fukita, Masahiko Saitoh & Sorou Takeda. (2014) Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma. Respiratory Medicine Case Reports 11, pages 7-11.
Crossref
Crossref
Ritesh Agarwal, Gella Vishwanath, Ashutosh N. Aggarwal, Mandeep Garg, Dheeraj Gupta & Arunaloke Chakrabarti. (2013) Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses 56:5, pages 559-570.
Crossref
Crossref
K. Oshima, Y. Kanda, S. Kako, K. Ohno, S. Kishino & M. Kurokawa. (2013) Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease 15:3, pages 323-327.
Crossref
Crossref
B. Pilmis, A. Lopes, O. Lortholary & C. Charlier. (2013) Les échinocandines : mise au point. Journal des Anti-infectieux 15:2, pages 83-94.
Crossref
Crossref
Keitaro Nakamoto, Noboru Takayanagi, Tetsu Kanauchi, Takashi Ishiguro, Tsutomu Yanagisawa & Yutaka Sugita. (2013) Prognostic Factors in 194 Patients with Chronic Necrotizing Pulmonary Aspergillosis. Internal Medicine 52:7, pages 727-734.
Crossref
Crossref
Koichi Izumikawa, Masato Tashiro & Shigeru Kohno. (2012) Management of chronic pulmonary aspergillosis. Annals of the New York Academy of Sciences 1272:1, pages 40-48.
Crossref
Crossref
A.J. Ullmann, M. Akova, R. Herbrecht, C. Viscoli, M.C. Arendrup, S. Arikan-Akdagli, M. Bassetti, J. Bille, T. Calandra, E. Castagnola, O.A. Cornely, J.P. Donnelly, J. Garbino, A.H. Groll, W.W. Hope, H.E. Jensen, B.J. Kullberg, C. Lass-Flörl, O. Lortholary, W. Meersseman, G. Petrikkos, M.D. Richardson, E. Roilides, P.E. Verweij & M. Cuenca-Estrella. (2012) ESCMID
guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clinical Microbiology and Infection 18, pages 53-67.
Crossref
Crossref
J. Cadranel, B. Philippe, C. Hennequin, A. Bergeron, E. Bergot, A. Bourdin, V. Cottin, T. Jeanfaivre, C. Godet, M. Pineau & P. Germaud. (2012) Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. European Journal of Clinical Microbiology & Infectious Diseases 31:11, pages 3231-3239.
Crossref
Crossref
Yuichi Muraki. (2012) Factors Affecting the Pharmacokinetics after Living Donor Liver Transplant生体肝移植後の薬物動態に影響を及ぼす因子に関する研究. YAKUGAKU ZASSHI 132:9, pages 1011-1017.
Crossref
Crossref
Maria N. Gamaletsou, Nikolaos V. Sipsas & Dimitrios P. Kontoyiannis. (2012) Micafungin in haematology. Mycoses 55:s1, pages 13-23.
Crossref
Crossref
Minoru Yoshida, Kazuo Tamura, Masahiro Imamura, Yoshiro Niitsu, Takeshi Sasaki, Akio Urabe, Kazuma Ohyashiki, Tomoki Naoe, Akihisa Kanamaru, Mitsune Tanimoto & Tohru Masaoka. (2011) Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders. Annals of Hematology 91:3, pages 449-457.
Crossref
Crossref
Minoru Yoshida. (2012) 3. Development of New Antifungal Drugs3．新規抗真菌薬の開発. Nihon Naika Gakkai Zasshi 101:11, pages 3185-3191.
Crossref
Crossref
Masaki Fujita, Hiroshi Ouchi, Eiji Harada, Satoshi Ikegame, Yoichi Nakanishi, Masaki Fujita, Takemasa Matsumoto, Junji Uchino, Kentaro Watanabe, Yoshiaki Tao & Akira Kajiki. (2012) The clinical efficacy and safety of micafungin–itraconazole combination therapy in patients with pulmonary aspergilloma. Journal of Infection and Chemotherapy 18:5, pages 668-674.
Crossref
Crossref
Masaki Yamaguchi, Toshiro Kurokawa, Ken Ishiyama, Go Aoki, Mikio Ueda, Sadaya Matano, Akiyoshi Takami, Hirohito Yamazaki, Aiko Sawazaki, Hiromasa Yamauchi, Takashi Yoshida & Shinji Nakao. (2011) Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study. Annals of Hematology 90:10, pages 1209-1217.
Crossref
Crossref
Tomoko Hanadate, Masahiro Wakasugi, Keizo Sogabe, Toshimitsu Kobayashi, Hisanori Horita, Ikuo Kawamura, Keita Matsui, Masahiro Sou, Yasuhiro Hori & Yo Hoshino. (2011) Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report. Journal of Infection and Chemotherapy 17:5, pages 622-632.
Crossref
Crossref
Koichi Izumikawa, Takahiro Takazono & Shigeru Kohno. (2010) Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance. Current Opinion in Infectious Diseases 23:6, pages 584-589.
Crossref
Crossref
Shigeru Kohno, Koichi Izumikawa, Kenji Ogawa, Atsuyuki Kurashima, Niro Okimoto, Ryoichi Amitani, Hiroshi Kakeya, Yoshihito Niki & Yoshitsugu Miyazaki. (2010) Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan. Journal of Infection 61:5, pages 410-418.
Crossref
Crossref
Naoe Goto, Takeshi Hara, Hisashi Tsurumi, Kengo Ogawa, Junichi Kitagawa, Nobuhiro Kanemura, Senji Kasahara, Toshiki Yamada, Masahito Shimizu, Mitsuhiro Nakamura, Katsuhiko Matsuura & Hisataka Moriwaki. (2010) Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies. American Journal of Hematology 85:11, pages 872-876.
Crossref
Crossref
Fedja Farowski, Jörg J Vehreschild, Oliver A Cornely & Maria JGT Vehreschild. (2010) Micafungin in a nutshell: state of affairs on the pharmacological and clinical aspects of the novel echinocandin. Therapy 7:5, pages 555-563.
Crossref
Crossref
M. W. Pound, M. L. Townsend & R. H. Drew. (2010) Echinocandin pharmacodynamics: review and clinical implications. Journal of Antimicrobial Chemotherapy 65:6, pages 1108-1118.
Crossref
Crossref
Hae-Seong Nam, Kyeongman Jeon, Sang-Won Um, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O. Jung Kwon & Won-Jung Koh. (2010) Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. International Journal of Infectious Diseases 14:6, pages e479-e482.
Crossref
Crossref
Hideki Teshima, Hiroshi Kawano, Hideyuki Kashikie, Katsuhiko Nakamura & Shigeaki Aoyagi. (2010) Coronary artery bypass grafting in patients with pulmonary aspergillosis. General Thoracic and Cardiovascular Surgery 58:4, pages 197-201.
Crossref
Crossref
Hsin-Yun Sun & Nina Singh. (2010) Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review. International Journal of Antimicrobial Agents 35:3, pages 211-218.
Crossref
Crossref
JOHN H. REX & DAVID A. STEVENS. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
549
563
.
Melissa Johnson & John Mohr. 2009. Antifungal Therapy. Antifungal Therapy
219
242
.
Yasuhiko KITASATO, Yoshiaki TAO, Tomoaki HOSHINO, Kousuke TACHIBANA, Naoko INOSHIMA, Makoto YOSHIDA, Shohei TAKATA, Kan OKABAYASHI, Masayuki KAWASAKI, Tomoaki IWANAGA & Hisamichi AIZAWA. (2009)
Comparison of
Aspergillus
galactomannan antigen testing with a new cut‐off index and
Aspergillus
precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis
. Respirology 14:5, pages 701-708.
Crossref
Crossref
Miguel Salavert-Lletí & Rafael Zaragoza-Crespo. (2009) Papel futuro de la micafungina en el tratamiento de las micosis invasoras por hongos filamentosos. Revista Iberoamericana de Micología 26:1, pages 81-89.
Crossref
Crossref
Mercedes Catalán-González & Juan Carlos Montejo-González. (2009) Farmacodinamia y farmacocinética de la micafungina en adultos, niños y neonatos. Revista Iberoamericana de Micología 26:1, pages 23-34.
Crossref
Crossref
Yuichi Muraki, Takuya Iwamoto, Yoshiyuki Kagawa, Hiroyuki Sakurai, Masanobu Usui, Shuji Isaji, Shinji Uemoto & Masahiro Okuda. (2009) The Impact of Total Bilirubin on Plasma Micafungin Levels in Living-Donor Liver Transplantation Recipients with Severe Liver Dysfunction. Biological and Pharmaceutical Bulletin 32:4, pages 750-754.
Crossref
Crossref
Jill A. Hoffman. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
1058
1082
.
Naoki Aikawa, Shinya Kusachi, Shigeto Oda, Yoshio Takesue & Hideharu Tanaka. (2009) Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm. Journal of Infection and Chemotherapy 15:4, pages 219-227.
Crossref
Crossref
Yasunori Nakagawa, Yoko Ichii, Yasuhiro Saeki, Masanobu Kodama, Satoshi Kishino & Kenshi Suzuki. (2008) Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies. European Journal of Drug Metabolism and Pharmacokinetics 33:3, pages 191-198.
Crossref
Crossref
O. A. Cornely. (2008) Aspergillus to Zygomycetes: Causes, Risk Factors, Prevention, and Treatment of Invasive Fungal Infections. Infection 36:4, pages 296-313.
Crossref
Crossref
W. J. Heinz & H. Einsele. (2008) Caspofungin for treatment of invasive aspergillus infections. Mycoses 51:s1, pages 47-57.
Crossref
Crossref
John Mohr, Melissa Johnson, Travis Cooper, James S. Lewis & Luis Ostrosky‐Zeichner. (2012) Current Options in Antifungal Pharmacotherapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:5, pages 614-645.
Crossref
Crossref
Hiroshi Kakeya, Yoshitsugu Miyazaki, Hisato Senda, Tsutomu Kobayashi, Masafumi Seki, Koichi Izumikawa, Kazunori Yanagihara, Yoshihiro Yamamoto, Takayoshi Tashiro & Shigeru Kohno. (2008) Efficacy of SPK-843, a Novel Polyene Antifungal, in Comparison with Amphotericin B, Liposomal Amphotericin B, and Micafungin against Murine Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy 52:5, pages 1868-1870.
Crossref
Crossref
P. Montravers, V. Chterev, P. Augustin & L. Etchegoyen. (2008) Nouvelles approches thérapeutiques des infections fongiques : place des nouvelles molécules. Antibiotiques 10:1, pages 25-34.
Crossref
Crossref
Benjamin D. Brielmaier, Ed Casabar, Christine M. Kurtzeborn, Peggy S. McKinnon & David J. Ritchie. (2012) Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:1, pages 64-73.
Crossref
Crossref
William J. Steinbach & Robert A. CramerJrJr. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
1178
1185
.
George Petrikkos & Anna Skiada. (2007) Recent advances in antifungal chemotherapy. International Journal of Antimicrobial Agents 30:2, pages 108-117.
Crossref
Crossref
Paul Juang. (2007) Update on New Antifungal Therapy. AACN Advanced Critical Care 18:3, pages 253-260.
Crossref
Crossref
Ken Sato, Minoru Hayashi, Mitsuyoshi Utsugi, Takahiro Ishizuka, Hitoshi Takagi & Masatomo Mori. (2007) Acute Pancreatitis in a Patient Treated with Micafungin. Clinical Therapeutics 29:7, pages 1468-1473.
Crossref
Crossref
Christopher C. Blyth, Pamela Palasanthiran & Tracey A. O'Brien. (2007) Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review. Pediatrics 119:4, pages 772-784.
Crossref
Crossref
Diane Cappelletty & Kasi Eiselstein‐McKitrick. (2012) The Echinocandins. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:3, pages 369-388.
Crossref
Crossref
Gregory Eschenauer, Daryl D DePestel & Peggy L Carver. (2007) Comparison of echinocandin antifungals. Therapeutics and Clinical Risk Management 3:1, pages 71-97.
Crossref
Crossref
Tomomi Toubai, Junji Tanaka, Shuichi Ota, Akio Shigematsu, Yusuke Shono, Makoto Ibata, Satoshi Hashino, Takeshi Kondo, Yasutaka Kakinoki, Nobuo Masauzi, Masaharu Kasai, Hiroshi Iwasaki, Mitsutoshi Kurosawa, Masahiro Asaka & Masahiro Imamura. (2007) Efficacy and safety of Micafungin in Febrile NeutropenicPatients Treated for Hematological Malignancies. Internal Medicine 46:1, pages 3-9.
Crossref
Crossref
Jomy M. Joseph, Rupali Jain & Larry H. Danziger. (2012) Micafungin: A New Echinocandin Antifungal. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:1, pages 53-67.
Crossref
Crossref
Yasuo Ota, Keita Tatsuno, Shu Okugawa, Shintaro Yanagimoto, Takatoshi Kitazawa, Atsuhito Fukushima, Kunihisa Tsukada & Kazuhiko Koike. (2007) Relationship between the initial dose of micafungin and its efficacy in patients with candidemia. Journal of Infection and Chemotherapy 13:4, pages 208-212.
Crossref
Crossref
Yasunori Nakagawa, Kenshi Suzuki, Yoko Ichii, Yasuhiro Saeki, Masanobu Kodaka & Satoshi Kishino. (2007) Plasma concentration of micafungin in patients with hematologic malignancies. Journal of Infection and Chemotherapy 13:1, pages 39-45.
Crossref
Crossref
Khaled H. Abu-Elteen & Mawieh M. Hamad. 2007. New Insights in Medical Mycology. New Insights in Medical Mycology
69
98
.
Gloria P. Heresi, Dale R. Gerstmann, Michael D. Reed, John N. van den Anker, Jeffrey L. Blumer, Laura Kovanda, James J. Keirns, Donald N. Buell & Gregory L. Kearns. (2006) The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants. The Pediatric Infectious Disease Journal 25:12, pages 1110-1115.
Crossref
Crossref
David W. Denning, Kieren A. Marr, Wendi M. Lau, David P. Facklam, Voravit Ratanatharathorn, Cornelia Becker, Andrew J. Ullmann, Nita L. Seibel, Patricia M. Flynn, Jo-Anne H. van Burik, Donald N. Buell & Thomas F. Patterson. (2006) Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. Journal of Infection 53:5, pages 337-349.
Crossref
Crossref
Elias K. Spanakis, George Aperis & Eleftherios Mylonakis. (2006) Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage. Clinical Infectious Diseases 43:8, pages 1060-1068.
Crossref
Crossref
Michele I. Morris & Mark Villmann. (2006) Echinocandins in the management of invasive fungal infections, part 1. American Journal of Health-System Pharmacy 63:18, pages 1693-1703.
Crossref
Crossref
Elizabeth S. Dodds Ashley. (2012) Treatment Options for Invasive Fungal Infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:6P2.
Crossref
Crossref
Kenji Tabata, Masataka Katashima, Akio Kawamura, Akira Kagayama & Shigeru Kohno. (2006) Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis. European Journal of Drug Metabolism and Pharmacokinetics 31:2, pages 123-128.
Crossref
Crossref
P. H. Chandrasekar & J. D. Sobel. (2006) Micafungin: A New Echinocandin. Clinical Infectious Diseases 42:8, pages 1171-1178.
Crossref
Crossref
Masamitsu Yanada, Hitoshi Kiyoi, Makoto Murata, Momoko Suzuki, Masanori Iwai, Toshiya Yokozawa, Hisashi Baba, Nobuhiko Emi & Tomoki Naoe. (2006) Micafungin, a Novel Antifungal Agent, as Empirical Therapy in Acute Leukemia Patients with Febrile Neutropenia. Internal Medicine 45:5, pages 259-264.
Crossref
Crossref
Kenji Tabata, Masataka Katashima, Akio Kawamura, Atsunori Kaibara & Yusuke Tanigawara. (2006) Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections. Drug Metabolism and Pharmacokinetics 21:4, pages 324-331.
Crossref
Crossref
Kenji TabataMasataka KatashimaAkio KawamuraYusuke Tanigawara & Keisuke Sunagawa. (2006) Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections. Biological and Pharmaceutical Bulletin 29:8, pages 1706-1711.
Crossref
Crossref
Daniel S. Loo. (2006) Systemic Antifungal Agents: An Update of Established and New Therapies. Advances in Dermatology 22, pages 101-124.
Crossref
Crossref
Roberto Di Santo. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41
299
315
.
L. Ostrosky-Zeichner, D. Kontoyiannis, J. Raffalli, K. M. Mullane, J. Vazquez, E. J. Anaissie, J. Lipton, P. Jacobs, J. H. Jansen Rensburg, J. H. Rex, W. Lau, D. Facklam & D. N. Buell. (2005) International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. European Journal of Clinical Microbiology & Infectious Diseases 24:10, pages 654-661.
Crossref
Crossref
Dennis J. CadaTerri LevienDanial E. Baker. (2017) Micafungin Sodium. Hospital Pharmacy 40:8, pages 693-704.
Crossref
Crossref
Jacques Bille, Oscar Marchetti & Thierry Calandra. (2005) Changing face of health-care associated fungal infections. Current Opinion in Infectious Diseases 18:4, pages 314-319.
Crossref
Crossref
Charalampos Antachopoulos & Thomas J Walsh. (2005) New agents for invasive mycoses in children. Current Opinion in Pediatrics 17:1, pages 78-87.
Crossref
Crossref
Neil Soni & Adrian Wagstaff. (2005) Fungal infection. Current Anaesthesia & Critical Care 16:4, pages 231-241.
Crossref
Crossref
Peggy L Carver. (2004) Micafungin. Annals of Pharmacotherapy 38:10, pages 1707-1721.
Crossref
Crossref